12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
During Friday's pre-market session, several health care stocks experienced significant movements. Ainos, Frequency Therapeutics, Nutriband, Monopar Therapeutics, Mallinckrodt, and OKYO Pharma saw increases in their stock prices, while Theseus Pharmaceuticals, Petros Pharma, Caribou Biosciences, PAVmed, MSP Recovery, and Veradigm experienced decreases.
July 14, 2023 | 1:12 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Caribou Biosciences shares decreased by 15.24% to $6.9.
The significant decrease in Caribou Biosciences' stock price could lead to short-term negative momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
MSP Recovery shares fell 11.16% to $0.26.
The significant decrease in MSP Recovery's stock price could lead to short-term negative momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Veradigm shares declined by 9.17% to $11.82.
The significant decrease in Veradigm's stock price could lead to short-term negative momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
PAVmed shares fell 13.23% to $0.35.
The significant decrease in PAVmed's stock price could lead to short-term negative momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Petros Pharma shares declined by 15.26% to $3.0.
The significant decrease in Petros Pharma's stock price could lead to short-term negative momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Theseus Pharmaceuticals stock decreased by 65.2% to $3.31.
The significant decrease in Theseus Pharmaceuticals' stock price could lead to short-term negative momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Ainos stock increased by 71.3% to $1.25.
The significant increase in Ainos' stock price could lead to short-term positive momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Frequency Therapeutics stock rose 62.22% to $0.65.
The significant increase in Frequency Therapeutics' stock price could lead to short-term positive momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Mallinckrodt stock moved upwards by 19.14% to $1.12.
The significant increase in Mallinckrodt's stock price could lead to short-term positive momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Monopar Therapeutics shares increased by 20.6% to $1.03.
The significant increase in Monopar Therapeutics' stock price could lead to short-term positive momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Nutriband shares moved upwards by 30.83% to $3.14.
The significant increase in Nutriband's stock price could lead to short-term positive momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
OKYO Pharma stock moved upwards by 18.84% to $1.28.
The significant increase in OKYO Pharma's stock price could lead to short-term positive momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100